跳至主要内容
临床试验/JPRN-UMIN000011673
JPRN-UMIN000011673尚未招募1 期

The safety of novel gut peptide ghrelin for the treatment of chronic kidney disease - The safety ofghrelin

Keio University, Scool of Medicine, Division of nephrology, endocrinology, and metabolism0 个研究点目标入组 6 人开始时间: 2013年9月10日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. subjects with severe liver dysfunction 2. subjects with neoplasma 3. subjects with severe infection 4. subjects with psychogenic disorder 5. sujects with allergic reaction to wheat, egg, and milk 6. pregnant women 7. subjects tha were not egligble for the stusy

研究者

发起方
Keio University, Scool of Medicine, Division of nephrology, endocrinology, and metabolism

相似试验